SWARTZ ROBIN (Chief Operating Officer) sold 1.8% of their position (3.88K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001104659-26-018131
Officer· Chief Operating Officer
Since Feb 2022
-3.88K
Net shares
Net seller
$13.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.88K
Price / share
$3.44
Trade value
$13.35K
% of position
1.8%
2/18/2026
210.08K→206.20K
Total
Net shares
−3.88K
Net value
-$13.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −3.88K | $3.44 | $13.35K | 1.8% | 210.08K | 206.20K |
| Total | −3.88K | -$13.35K | ||||||
Derivative Transactions0
No derivative transactions reported